The Venture Codex Logo

The Venture Codex

Beaker DAO

San Francisco, CA, United States

Overview

Beaker DAO is a group that promotes the growth of decentralised science. The DAO aims to promote open accessibility and decentralised market liquidity across the DeSci space by funding research and managing intellectual property.

Total investments
2
Lead investments
0
Investments · 12mo
0
Active investors
1
Visit website

Investment portfolio

  • LabDAO

    Participated · Equity · May 2023

    LabDAO is focused on open-source drug discovery and is building an exchange to connect scientists with laboratory and computational services. The project launched PLEX, a client that lets scientists interact with the Lab exchange and run containerized, resource-intensive computational services. PLEX currently supports computational workflows only; physical laboratory services are planned for a future release. LabDAO enables outputs to be linked to NFTs so scientists can prove ownership of their data. The DAO governance structure is not yet fully in place; the team is prioritizing building utility and an active community before deploying the DAO and affiliated token. The project raised $3.6M in a funding round co-led by Inflection.xyz and Village Global.

  • VitaDAO

    Participated · Equity · Feb 2023

    VitaDAO is a decentralized autonomous organization (DAO) that crowdsources funding for research into extending human life, with a focus on cellular biology and repairing damage tied to the hallmarks of ageing. The organization aggregates capital from venture backers, web3/decentralized-science groups, and individual longevity enthusiasts to finance R&D and spinouts. It has a global community of over 9,000 enthusiasts, researchers, and contributors and in 2022 deployed over $3.5M across 15+ projects researching diseases of ageing. VitaDAO holds IP as NFT assets and is pursuing commercialization and licensing of those assets through a partnership with Molecule DAO. The DAO intends to use newly raised capital to fund further longevity research projects and to precede the spinout of its first biotech startups, scheduled for the first quarter of 2023. The organization was founded by Tyler Golato.

Team